Comparing high-flow nasal oxygen to standard oxygen for thoracic surgery patients
High-Flow Nasal Catheter (HFNC) Compared With Conventional Oxygenation During the Perioperative Period of Patients Undergoing Thoracic Surgery.
This study is testing if high-flow nasal oxygen can help patients having thoracic surgery breathe better and avoid complications compared to standard oxygen.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Federal University of Rio Grande do Sul Academic / other |
| Locations | 1 site (Bento Gonçalves, Rio Grande Do Sul) |
| Trial ID | NCT05910788 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of high-flow nasal cannula (HFNC) oxygen therapy compared to conventional oxygenation during the perioperative period for patients undergoing thoracic surgery. It aims to assess the incidence of pulmonary complications, mortality, and hypoxemia during intubation and extubation. By analyzing these outcomes, the study seeks to determine if HFNC can improve lung function and overall patient outcomes in this surgical population. The research is particularly relevant given the high volume of thoracic surgeries performed globally and the associated risks of complications.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old scheduled for elective thoracic surgery with an ARISCAT score greater than 26.
Not a fit: Patients requiring urgent or emergency surgery, pregnant women, or those with an ARISCAT score of 26 or lower may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved respiratory outcomes and reduced complications for patients undergoing thoracic surgery.
How similar studies have performed: While the use of HFNC in various settings has shown promise, this specific application in thoracic surgery is relatively novel and not extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients over 18 years of age who will undergo elective thoracic surgery and who have an ARISCAT score \> 26. Exclusion Criteria: * Patients who need urgent/emergency surgery, pregnant women, who do not have an ARISCAT score \> 26 and those who refuse to participate in the study.
Where this trial is running
Bento Gonçalves, Rio Grande Do Sul
- Desejo Tarso Maioli — Bento Gonçalves, Rio Grande Do Sul, Brazil (Recruiting)
Study contacts
- Study coordinator: Desire Maioli
- Email: desiremaioli@gmail.com
- Phone: 55(54)999556129
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.